tiprankstipranks
FibroGen Cuts Costs by Terminating San Francisco Lease Early
Company Announcements

FibroGen Cuts Costs by Terminating San Francisco Lease Early

Pick the best stocks and maximize your portfolio:

FibroGen ( (FGEN) ) has issued an update.

FibroGen, Inc. has taken a strategic step to cut costs and safeguard its finances by terminating its lease early with landlord ARE-San Francisco No. 43 Owner, LLC for the property at 409 Illinois Street, San Francisco. The agreement, effective December 31, 2024, involves a $10 million settlement to cover past dues and a security deposit, freeing FibroGen from future rental and associated expenses. This move is aimed at improving the company’s cash flow and operational efficiency.

For a thorough assessment of FGEN stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyFibroGen initiated with a Buy at H.C. Wainwright
TipRanks Auto-Generated NewsdeskFibroGen Appoints David DeLucia as CFO
TheFlyFibroGen appoints David DeLucia as CFO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App